Most Pharmacies assume that when a patient nomination moves It is because the patient made a conscious choice
A patient who has been with you for years — sometimes decades — suddenly stops receiving their prescriptions through your system.
In reality, that is only part of the picture, Across the sector, nomination losses typically fall into three distinct categories
Legitimate Patient Choice
Location or convenience
Delivery preferences
Changes in routine or circumstances
These decisions are valid and should always be respected.
Renominate does not intervene in these cases.
Administrative or System-Driven Changes
Misunderstandings during service interactions
Poorly explained consent requests
Administrative shortcuts
Digital processes that lack clear patient confirmation
In these cases, patients may not realise a change has taken place until something goes wrong with their prescription.
The Growing Issue: Unsolicited and Incentivised Targeting
An increasing concern across the sector is the rise of unsolicited patient targeting, where pharmacies actively contact patients who are not their existing customers.
This may include:
Cold calls, texts, or leaflets
Online advertising targeting specific patient groups
Promotional messaging framed as “help” or “convenience”
Incentives such as vouchers, rewards, or inducements
Renominating patients without consent in bulk using software automation
In some cases, patients are led to believe they are:
Updating their details
Confirming a service
Registering for delivery
Accessing a benefit
Without realising they have agreed to change their nominated pharmacy.
Many patients later report:
They did not understand what they were agreeing to
They did not intend to leave their existing pharmacy
They were unaware a nomination change had even occurred
Why This Matters for Pharmacies
Prescription volume is lost unfairly
Long-standing patient relationships are disrupted
Continuity of care is broken
Trust in the system is undermined
For pharmacies on the receiving end, the impact can be significant — yet difficult to challenge without a clear, compliant process.
Where Renominate Fits In
Renominate exists to address only one part of this problem:
Identifying situations where a nomination changed without patient awareness
Giving patients clarity about what actually happened
Allowing patients to decide what they want to do next
We do not market.
We do not incentivise.
We do not interfere with legitimate choice.
We simply bring visibility and fairness back into a process that has become increasingly opaque.
As competition intensifies, the pharmacies that act professionally should not be the ones quietly losing patients they never meant to give up.
A better experience for your patients.
A stronger relationship for your pharmacy.
When a patient returns through RE-NOMINATE something important happens. They do not just regain their familiar pharmacy. They regain confidence. They regain clarity. They regain the certainty of a relationship they thought they had never left.
And your pharmacy regains a meaningful connection that should never have been lost in the first place.
Founder Partner Opportunity
We are currently welcoming a limited number of pharmacies to join as Founder Partners during the structured launch phase of the Renominate programme.
Founder Partners participate at the ground-floor stage of a carefully designed retention and digital credibility framework. During this phase, each partner receives direct oversight and measured implementation support to ensure long-term stability and success.
Founder Partner status includes:
• Direct founder-led implementation and strategic oversight
• Priority onboarding within the structured rollout phase
• Protected long-term commercial positioning within the programme
• Preferential access to all Renominate services and future enhancements
• Participation within a limited, quality-controlled launch cohort
Launch intake is intentionally restricted to ensure every Founder Partner receives the level of attention and structure the programme requires.
